Supernus Pharm (SUPN) Posts Q4 Loss of 51c/Share
Supernus Pharm (NASDAQ: SUPN) reported Q4 ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
